Sequential therapy for H. pylori: An 'aberrant' therapy ready for general use (multiple letters) [1]

Digestive and Liver Disease

Volumn 36, Issue 12, 2004, Pages 852-853

  Zullo, A ^a   Hassan, C ^a   Morini, S ^a   De Francesco, V ^b   Ierardi, E ^b   Panella, C ^b   Gatta, L ^c   Vaira, D ^c   de Boer, W A ^d   Kuipers, E J ^e   Kusters, H G ^e  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d BERNHOVEN HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; ANTIULCER AGENT; DRUG DERIVATIVE; RANITIDINE; RANITIDINE BISMUTH CITRATE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; DRUG EFFICACY; DRUG INTOXICATION; DRUG USE; DUODENUM ULCER; ERADICATION THERAPY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; NONHUMAN; TREATMENT OUTCOME; DRUG ADMINISTRATION; DRUG COMBINATION; NOTE;

ANTI-ULCER AGENTS; BISMUTH; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RANITIDINE;

EID: 23044501839     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.08.005     Document Type: Letter

References (12)

1. W.A. de Boer E.J. Kuipers J.G. Kusters Sequential therapy: a new treatment for Helicobacter pylori infection. But it is ready for general use? Dig Liver Dis 36 2004 311 314
2. E. Genè X. Calvet R. Azagra J.P. Gisbert Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis Aliment Pharmacol Ther 18 2003 543 544
3. D.Y. Graham G. Belson S. Abudayyedi M.S. Osato M.P. Dore H.M.T. El Zimaity Twice daily (mid day and evening) quadruple therapy for H. pylori infection in the United States Dig Liver Dis 36 2004 384 387
4. A. Zullo C. Hassan S. Morini Quadruple therapy as a first-line Helicobacter pylori treatment: past or future? Dig Liver Dis 36 2004 377 379
5. L. Laine R. Hunt H. El-Zimaity B. Nguyen M. Osato J. Spenard Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial Am J Gastroenterol 98 2003 562 567
6. R.H. Phillips M.W. Whitehead L.A. Doig C.E. Sieniawska H.T. Delves R.P. Thompson Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe? Helicobacter 6 2001 151 156
7. A. Pilotto M. Rassu G. Leandro M. Franceschi F. Di Mario Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study Dig Liver Dis 32 2000 763 768
8. S. Toracchio L. Cellini E. Di Campli G. Cappello M.G. Malatesta A. Ferri Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication Aliment Pharmacol Ther 14 2000 1639 1643
9. A. Zullo D. Vaira N. Vakil C. Hassan L. Gatta C. Ricci High eradication rates of Helicobacter pylori with a new sequential treatment Aliment Pharmacol Ther 17 2003 719 726
10. W.A. de Boer How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients J Clin Gastroenterol 22 1996 313 316
11. Gatta L, Ricci C, Zullo A, De Francesco V, Perna F, Tampieri A, et al. High eradication rate with a rescue levofloxacin-based treatment for Helicobacter pylori . DDW New Orleans, in press.
12. A. Zullo C. Hassan R. Lorenzetti M. Marignani S. Angeletti D. Porto A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication Dig Liver Dis 35 2003 232 236